HomeInsightsStock Comparison

Auro Laboratories Ltd vs Rekvina Labs Ltd Stock Comparison

Auro Laboratories Ltd vs Rekvina Labs Ltd Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

  • The Latest Trading Price of Auro Laboratories Ltd is ₹ 239.1 as of 30 Apr 15:30 . The P/E Ratio of Auro Laboratories Ltd changed from 7 on March 2021 to 78.2 on March 2025 . This represents a CAGR of 62.04% over 5 yearsThe P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Auro Laboratories Ltd changed from ₹ 50.55 crore on March 2021 to ₹ 143.69 crore on March 2025 . This represents a CAGR of 23.24% over 5 yearsThe Market Cap of Rekvina Labs Ltd changed from ₹ 2.39 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Auro Laboratories Ltd for the Sep '25 is ₹ 9.81 crore as compare to the Jun '25 revenue of ₹ 3.19 crore. This represent the growth of 207.52% The revenue of Rekvina Labs Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Auro Laboratories Ltd for the Sep '25 is ₹ 3.33 crore as compare to the Jun '25 ebitda of ₹ 0.45 crore. This represent the growth of 640% The ebitda of Rekvina Labs Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Auro Laboratories Ltd changed from ₹ 0.75 crore to ₹ 0.72 crore over 4 quarters. This represents a CAGR of -4.00% The net profit of Rekvina Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Rekvina Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Auro Laboratories Ltd

  • Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
  • Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
  • The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
  • The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
  • Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

About Rekvina Labs Ltd

  • Rekvina Labs Limited was incorporated on 1st November 1988.
  • From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore.
  • It is registered in England and Wales as a Public Limited Company.
  • The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements.
  • It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products.

FAQs for the comparison of Auro Laboratories Ltd and Rekvina Labs Ltd

Which company has a larger market capitalization, Auro Laboratories Ltd or Rekvina Labs Ltd?

Market cap of Auro Laboratories Ltd is 149 Cr while Market cap of Rekvina Labs Ltd is 26 Cr

What are the key factors driving the stock performance of Auro Laboratories Ltd and Rekvina Labs Ltd?

The stock performance of Auro Laboratories Ltd and Rekvina Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Auro Laboratories Ltd and Rekvina Labs Ltd?

As of May 3, 2026, the Auro Laboratories Ltd stock price is INR ₹239.1. On the other hand, Rekvina Labs Ltd stock price is INR ₹43.3.

How do dividend payouts of Auro Laboratories Ltd and Rekvina Labs Ltd compare?

To compare the dividend payouts of Auro Laboratories Ltd and Rekvina Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions